Results 21 to 30 of about 14,295 (215)
Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease
Frontiers in Aging Neuroscience, 2023 BackgroundSeveral blood-based biomarkers are promising to be used in the diagnosis of Alzheimer’s disease (AD) including Aβ42/40, p-tau181, and neurofilament light (NfL). The kidney is associated with the clearance of proteins.
Bin Zhang +7 more
doaj +1 more source
Dopamine in plasma – a biomarker for myofascial TMD pain? [PDF]
The Journal of Headache and Pain, 2016 Dopaminergic pathways could be involved in the pathophysiology of myofascial temporomandibular disorders (M-TMD). This study investigated plasma levels of dopamine and serotonin (5-HT) in patients with M-TMD and in healthy subjects.Fifteen patients with M-TMD and 15 age- and sex-matched healthy subjects participated.
Dawson, Andreas +6 more
openaire +6 more sources
CSF and plasma biomarkers for DLB [PDF]
Alzheimer's & Dementia, 2020 AbstractBackgroundCSF biomarkers of amyloid and tau provide components of the A/T/N classification for AD and hold clinical prognostic value. They can help to identify how AD co‐pathology contributes to DLB. Alpha‐synuclein (a‐Syn) aggregation is a key pathogenic process in DLB, proposed to follow a staging system for spread of pathology.
Doug R. Galasko +3 more
openaire +1 more source
Early functional neuroimaging alterations in pTau217 biomarker-positive older adults
Frontiers in Aging NeuroscienceIntroductionEarly identification of individuals with Alzheimer’s Disease (AD) is key to its successful management. In this regard, plasma biomarkers and functional magnetic resonance imaging alterations could represent useful triage tools for preclinical
Arianna Menardi +41 more
doaj +1 more source
Liver Cancer, 2021 Introduction: Cabozantinib, an inhibitor of MET, AXL, and VEGF receptors, significantly improved overall survival (OS) and progression-free survival (PFS) versus placebo in patients with previously treated advanced hepatocellular carcinoma (HCC). In this
Lorenza Rimassa +14 more
doaj +1 more source
Frontiers in ImmunologyIntroductionPlasma donor-derived cell-free DNA (dd-cfDNA) is an emerging potential tool for diagnosing lung graft injury. This study explored the relevance of dd-cfDNA levels in different graft injuries thoroughly characterized after a well-established ...
Fiorella Calabrese +17 more
doaj +1 more source
Early Gestational Blood Markers to Predict Preeclampsia Complicating Gestational Diabetes Mellitus
Diabetes, Metabolic Syndrome and Obesity, 2023 Yan Xie,1 Wenni Zhou,1 Xiang Tao,2 Hui Lv,3 Zhongping Cheng1 1Department of Obstetrics and Gynecology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, 200072, People’s Republic of China; 2Department of Pathology ...
Xie Y, Zhou W, Tao X, Lv H, Cheng Z
doaj
Plasma Biomarkers of HIV-associated Cognitive Disease [PDF]
EBioMedicine, 2016 By controlling human immunodeficiency virus (HIV) replication and allowing recovery of immune system function, combination antiretroviral therapy (cART) has revolutionised the outlook for people-living-with-HIV (PLWH) to that of a chronic but manageable medical condition.
Winston, Alan, Underwood, Jonathan
openaire +5 more sources
CellsThere is a subgroup of people infected with the SARS-CoV-2 virus who manifest lingering sequelae (LongC), with neurological symptoms (nLongC). We recruited 86 COVID-19 volunteers, 35 of whom were fully recovered (Cov) and 51 who had neurological symptoms
Norina Tang +3 more
doaj +1 more source
High Plasma sTNF-R1 Level Is Related to Loss of Natural HIV Control in Long-Term Elite Controllers
Frontiers in Cellular and Infection Microbiology, 2022 Human immunodeficiency virus-1 (HIV-1) elite controllers are heterogeneous due to different immunovirological features. We aimed to identify plasma biomarkers associated with loss of spontaneous HIV-1 control in long-term elite controllers (HIV-LTECs ...
Daniel Sepúlveda-Crespo +14 more
doaj +1 more source